Regis Technologies
Eric Buck is a highly experienced professional in the field of chemistry, currently serving as a Group Leader and Principal Scientist in Process Chemistry at Regis Technologies since October 2018. Prior to this role, Eric worked at Apiscent Labs as an R&D Chemist, focusing on the development and scale-up of APIs and flavor chemicals from May 2014 to September 2018. Eric's earlier experience includes a position as an R&D Chemist at Fontarome Chemical, Inc., and a Post-Doctoral Associate role at the University of Minnesota, where research centered on biorenewable polyisocyanates. Eric's academic background includes a Ph.D. in Organic Chemistry from the University of Pittsburgh and a Bachelor of Science in Chemistry from the University of Minnesota.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.